Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 468564013 | Betamethasone+salicylic acid 0.05/3% scalp application | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1192589010 | Betamethasone+salicylic acid 0.05/3% scalp application (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Betamethasone+salicylic acid 0.05/3% scalp application | Is a | Product containing betamethasone and salicylic acid (medicinal product) | false | Inferred relationship | Some | ||
| Betamethasone+salicylic acid 0.05/3% scalp application | Has active ingredient | Betamethasone | false | Inferred relationship | Some | ||
| Betamethasone+salicylic acid 0.05/3% scalp application | Has active ingredient | Adrenal hormone | false | Inferred relationship | Some | ||
| Betamethasone+salicylic acid 0.05/3% scalp application | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| Betamethasone+salicylic acid 0.05/3% scalp application | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Some | ||
| Betamethasone+salicylic acid 0.05/3% scalp application | Has active ingredient | Keratolytic agent | false | Inferred relationship | Some | ||
| Betamethasone+salicylic acid 0.05/3% scalp application | Has active ingredient | Salicylic acid (substance) | false | Inferred relationship | Some | ||
| Betamethasone+salicylic acid 0.05/3% scalp application | Has active ingredient | Topical agent | false | Inferred relationship | Some | ||
| Betamethasone+salicylic acid 0.05/3% scalp application | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| Betamethasone+salicylic acid 0.05/3% scalp application | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Betamethasone+salicylic acid 0.05/3% scalp application | Is a | Product containing salicylic acid in topical dosage form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR